The Ba/Sq subtype of BLCA was characterized by poor treatment responsiveness and heightened immune cell infiltration, which was further compounded by higher PD-L1 expression on both tumors and immune cells compared to luminal and stroma-rich subtypes. This evidence concerns the gene CD274 and bladder transitional cell carcinoma.